Skip to content

NUTRACEUTICAL INTERNATIONAL CORP

Delisted

CIK 1050007fmd_0VQ5HY0DX7WXK4EP4SC1ZNDBMHManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard

Coverage: Oct 01, 2008 to Jun 30, 2017, 30 periods

Latest annual · FY2016

Millions
Total revenues
233
Gross profit
118
Operating income
29
Free cash flow
24

Latest quarter · Q3 FY2017

Millions
Total revenues
65
Gross profit
33
Operating income
4
Free cash flow
3
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2013 to FY2016
+3.8%
Revenue, 5 yearsFY2011 to FY2016
+4.4%

NUTRACEUTICAL INTERNATIONAL CORP financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2016FY2015ChangeSource
Revenue$233 million$216.5 million+7.6%10-K 2016-11-17 · proof
Gross profit$118 million$106.2 million+11.1%10-K 2016-11-17 · proof
Operating income$29.2 million$24.3 million+20.1%10-K 2016-11-17 · proof
Cash from operating activities$32.8 million$25 million+30.9%10-K 2016-11-17 · proof
Free cash flow$23.8 million$16.5 million+44.5%10-K 2016-11-17 · proof
Total assets$235.9 million$212.4 million+11%10-K 2016-11-17 · proof
Total liabilities$63.9 million$52.2 million+22.3%10-K 2016-11-17 · proof
Cash and cash equivalents$6.8 million$4.6 million+47.4%10-K 2016-11-17 · proof
What was NUTRACEUTICAL INTERNATIONAL CORP's revenue in fiscal 2016?
NUTRACEUTICAL INTERNATIONAL CORP reported revenue of $233 million for fiscal 2016 (the year ended Sep 30, 2016), against $216.5 million the year before (+7.6%). Source: the 10-K filed with the SEC on Nov 17, 2016. SEC
What was NUTRACEUTICAL INTERNATIONAL CORP's gross profit in fiscal 2016?
NUTRACEUTICAL INTERNATIONAL CORP reported gross profit of $118 million for fiscal 2016 (the year ended Sep 30, 2016), against $106.2 million the year before (+11.1%). Source: the 10-K filed with the SEC on Nov 17, 2016. SEC
What was NUTRACEUTICAL INTERNATIONAL CORP's operating income in fiscal 2016?
NUTRACEUTICAL INTERNATIONAL CORP reported operating income of $29.2 million for fiscal 2016 (the year ended Sep 30, 2016), against $24.3 million the year before (+20.1%). Source: the 10-K filed with the SEC on Nov 17, 2016. SEC
What was NUTRACEUTICAL INTERNATIONAL CORP's cash from operating activities in fiscal 2016?
NUTRACEUTICAL INTERNATIONAL CORP reported cash from operating activities of $32.8 million for fiscal 2016 (the year ended Sep 30, 2016), against $25 million the year before (+30.9%). Source: the 10-K filed with the SEC on Nov 17, 2016. SEC
What was NUTRACEUTICAL INTERNATIONAL CORP's free cash flow in fiscal 2016?
NUTRACEUTICAL INTERNATIONAL CORP reported free cash flow of $23.8 million for fiscal 2016 (the year ended Sep 30, 2016), against $16.5 million the year before (+44.5%). Source: the 10-K filed with the SEC on Nov 17, 2016. SEC
What are NUTRACEUTICAL INTERNATIONAL CORP's total assets?
As of Sep 30, 2016, NUTRACEUTICAL INTERNATIONAL CORP reported total assets of $235.9 million, against $212.4 million a year earlier (+11%). Source: the 10-K filed with the SEC on Nov 17, 2016. SEC
What are NUTRACEUTICAL INTERNATIONAL CORP's total liabilities?
As of Sep 30, 2016, NUTRACEUTICAL INTERNATIONAL CORP reported total liabilities of $63.9 million, against $52.2 million a year earlier (+22.3%). Source: the 10-K filed with the SEC on Nov 17, 2016. SEC
What are NUTRACEUTICAL INTERNATIONAL CORP's cash and cash equivalents?
As of Sep 30, 2016, NUTRACEUTICAL INTERNATIONAL CORP reported cash and cash equivalents of $6.8 million, against $4.6 million a year earlier (+47.4%). Source: the 10-K filed with the SEC on Nov 17, 2016. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1050007&period_type=annual&limit=5"

Information only, not investment advice.